Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QB8Q
|
|||
| Former ID |
DIB015071
|
|||
| Drug Name |
EP-2167
|
|||
| Synonyms |
MX-2167; Transferrin modulating apoptosis inducers (cancer); Transferrin modulating apoptosis inducers (cancer), EpiCept;Transferrin modulating apoptosis inducers (cancer), Maxim
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Preclinical | [1] | |
| Company |
Maxim Pharmaceuticals Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Transferrin (TF) | Target Info | Inducer | [2] |
| KEGG Pathway | HIF-1 signaling pathway | |||
| Mineral absorption | ||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| Pathway Interaction Database | EPHB forward signaling | |||
| HIF-1-alpha transcription factor network | ||||
| Reactome | Platelet degranulation | |||
| Iron uptake and transport | ||||
| Transferrin endocytosis and recycling | ||||
| WikiPathways | SIDS Susceptibility Pathways | |||
| Differentiation Pathway | ||||
| Iron uptake and transport | ||||
| Iron metabolism in placenta | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017941) | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017941) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.